News

H.C. Wainwright Raises Purple Biotech (PPBT) Price Target, Reiterates Buy Rating
Emily Bodnar, an analyst at H.C. Wainwright, raised her price target for Purple Biotech Ltd. (NASDAQ:PPBT) from $33 to $34 ...
Investing13d
H.C. Wainwright lifts Purple Biotech stock target to $34
On Monday, H.C. Wainwright analyst Emily Bodnar increased the price target for Purple Biotech Ltd. (NASDAQ: PPBT) shares to $34 from the previous $33 while maintaining a Buy rating.Currently trading ...
Investing8mon
Purple Biotech price target raised by H.C. Wainwright, maintains Buy rating
Purple Biotech Ltd. (NASDAQ: PPBT) has received a significant price target increase from H.C. Wainwright, with the firm raising the target to $33 from the previous $8 while maintaining a Buy rating on ...
Investing11mon
Purple Biotech stock retains Buy rating from H.C. Wainwright
On Friday, H.C. Wainwright maintained a Buy rating and a $10.00 price target on shares of Purple Biotech Ltd. (NASDAQ: PPBT). The firm's stance follows a virtual KOL event held by Purple Biotech ...
Investing14d
H.C. Wainwright lifts Purple Biotech stock target to $34
On Monday, H.C. Wainwright analyst Emily Bodnar increased the price target for Purple Biotech Ltd. (NASDAQ: PPBT) shares to $34 from the previous $33 while maintaining a Buy rating.